Antonio Anzueto United States

Antonio R. Anzueto, MD, is an Emeritus Professor, Pulmonary Medicine/Critical Care, Department of Medicine, University of Texas Health at San Antonio in San Antonio, Texas, USA. In addition, he is the former - chief of the Pulmonary Section at the Audie L. Murphy Memorial Veterans Hospital of the South Texas Veterans Health Care System. He obtained his MD degree from the University of San Carlos in Guatemala City, Guatemala. He completed an internship and a residency in internal medicine at the UT Health Science Center at San Antonio, as well as fellowships in pulmonary diseases and critical care medicine. Dr. Anzueto joined the faculty at the University of Texas Health San Antonio in 1993.He worked in the division of Pulmonary Medicine and Critical Care. Dr Anzueto’s research interests include chronic obstructive pulmonary disease (COPD), community acquired pneumonia, acute respiratory disease syndrome, and acute exacerbations of chronic bronchitis. He has participated in diverse collaborative research projects, ranging from the genetics and bronchodilator treatment of COPD and the diagnosis and management of community-acquired pneumonia to the use of mechanical ventilation and the prevention of ventilator-associated pneumonia, to septic shock, and he has served as co-investigator of numerous studies in his areas of interest. The author or coauthor of more than 400 journal articles and over 30 book chapters, he is a reviewer for multiple medical journals, including The New England Journal of Medicine: American Journal of Respiratory Medicine and Critical Care etc. He is also regular speaker and national and International pulmonary conferences. Dr Anzueto is an active member of national and international professional organizations, including the American Thoracic Society, where he has served on various committees and task forces; the American College of Chest Physicians (CHEST); and the European Respiratory Society. He is a fellow of the American Thoracic Society and the European Respiratory Society. He is a fellow of the American Thoracic Society and European Respiratory Society. He is currently a member of the Science Committee of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and was a member of the Infectious Disease Society and American and American Thoracic Society Community Acquired pneumonia guidelines.
Job Title
Member of GOLD Science Committee
Faculty / Department / Division
Professor Medicine University of Texas Health, San Antonio
Institution / Organisation
Global Initiative for Chronic Obstructive Lung Disease – GOLD

20 November 2026, Friday

Time Session
09:30
11:00
  • Ahmad Izuanuddin Ismail Chairperson Malaysia
  • David Halpin Speaker United Kingdom
  • Antonio Anzueto Speaker United States
  • Wisia Wedzicha Speaker United Kingdom
    This presentation will review aspects of COPD exacerbation management in the GOLD 2027 report.
  • Pang Yong Kek Speaker Malaysia
    Title: Leveraging Digital Tools in COPD Management for 2027 & Beyond Routine outpatient management of COPD faces a double deficit: up to 70% of patients make critical inhaler errors, with real-world adherence below 50%, whilst fewer than 3% complete centre-based pulmonary rehabilitation (PR). Digital healthcare addresses this through two synergistic pillars: connected smart inhalers—which enhance adherence by 22%–35% and reduce exacerbations by 17%–30% via objective flow and technique tracking—and digital therapeutics like myCOPD and Kaia COPD, which improve exercise capacity (+57.68 m 6MWD) with outcomes non-inferior to in-person PR. Remote Therapeutic Monitoring (RTM) billing frameworks establish clinical and financial viability by reimbursing multidisciplinary management of non-physiological data, medication adherence, and patient-reported outcomes. Looking toward 2027, multi-modal data fusion—integrating wearable vitals, acoustic cough biomarkers, and smart inhaler actuations—enables machine learning algorithms to forecast acute exacerbations up to 7 days ahead with 92% accuracy, aligning with recent GOLD strategy updates on early phenotypes (Pre-COPD/PRISm) and AI integration. Crucially, digital tools fail in isolation: patient engagement drops to 20% without supervision but exceeds 85% within a structured "clinician-in-the-loop" model, proving human clinical oversight remains essential for successful digital transformation.
  • Ahmad Izuanuddin Ismail Chairperson Malaysia
    Pang Yong Kek Chairperson Malaysia
Ballroom 1, Lower Ground Floor
12:00
13:00
Sponsored by GlaxoSmithKline
Ahmad Izuanuddin Ismail Chairperson Malaysia
Ballroom 2, Lower Ground Floor